Curcumin for Cancer
Curcumin and Cancer

The common misconception is that holistic therapies are not founded in science or are good science. That could not be further from the truth. The counter assumption is that conventional medicine is founded on sound science. More, it is just founded in the “accepted” science. Just because you don’t see something doesn’t make it so. Just because you have no knowledge of a particular topic does not disqualify the legitimacy of that topic. The truth still exists. Truth does not need our approval or acceptance to exist. The denial of truth doesn’t make truth cease to exist. No matter the push to discredit or destroy truth, truth prevails. Ever see gravity? Ever research or read studies on gravity? Gravity’s existence is not contingent on you taking time to read, study, and acquire knowledge on the topic of gravity. Gravity is not the result of the accumulation of academic education or the collection of academic degrees. Regardless of belief, education level, or academic degree, gravity, and its effects are evident for all to see. Gravity is truth. The truth of gravity will make itself clear whether you believe in it or not.

The same concept of truth applies to holistic therapies. I have discussed previously that doctors historically do a terrible job of reading. The entire continuing medical education (CME) system has generated a culture of physicians with little independent curiosity beyond the accepted groupthink. This waste-land culture of deficit intellectual curiosity has generated a vast knowledge vacancy and the inability to acquire new knowledge or the means to remedy the lack of knowledge. Heck, there is no recognition of a void in knowledge.

Another propagated falsehood is that holistic therapies lack specificity in action. This falsehood ties in with the first point (above) that holistic therapies lack scientific validity. Both are attempts to discredit effective treatments that challenge the current, highly profitable paradigm that currently drives conventional medicine. This leads to the current problem of profits and power over the patient that adulterates the practice of medicine today. Just as the first falsehood lacks truth, the second lacks truth. If you have read any of my writings, watched any of my videos, or listened to any of my podcasts, it should be clear that I want to let science lead the way. It is about biochemistry. It is about physiology. The reproducibility of the mechanism of action of holistic therapies permeate vast amounts of the scientific literature; this highlights the lack of knowledge, lack of desire to gain new knowledge, and the groupthink that permeates so much of conventional medicine today.

Holistic is specific

Surprisingly, to most conventional docs, holistic and natural therapies are precise in their actions. Holistic therapies, such as curcumin, have exact signaling pathways, transcription mechanisms, metabolic effects, epigenetic effects, and anti-cancer mechanisms of action. The problem is that their specificity is so wide-reaching. Problem? The problem is because this kind of thinking doesn’t fit within the conventional mindset of linear cause and effect. This linear, sequential thinking among doctors today results from long-standing indoctrination in medical school, residencies, fellowships, and continuing medical education. The result is trained, more brainwashed, physicians who overly simplify the body’s physiology to the point of misrepresenting and misunderstanding how the body works. This miseducation teaches doctors not to think but to regurgitate the party line. The result is the inability to think big picture, out of the box, beyond the simple concept of simple cause and effect. In coming posts, I will dive more into the specifics of curcumin’s actions.

curcumin and cancerCurcumin

There is not a more researched or historically used potential therapy than curcumin. As of the writing of this post, the U.S. pubmed lists 16,987 articles on curcumin. In contrast, the European PMC equivalent lists 36,616 articles. These numbers are remarkable when considering the conventional mindset that creates counter pressure to research and publication on all things “alternative”, “natural”, or “holistic”.

What about history? It is throughout history where the validity of curcumin has stood the test of time. In our current history, never have we had access to so much information, yet done so little with it. In contrast, ancient cultures were incredible thinkers. Ancient cultures were able to do so much more with so little compared to the present day.

What about culture? Today, many view curcumin as a food or a spice. Curcumin appears to hit the history stage approximately 2000 BC. Many ancient cultures treasured its medicinal attributes. It was seen as medicine first and food later. In today’s hyper-compartmentalized groupthink, it is impossible to recognize that food is medicine. Medicine is food. Hippocrates, the father of western medicine, recognized and was credited as saying this thousands of years ago. Curcumin, which comes from the turmeric root, was heavily used by what I call the ancients—these are the ancient cultures that we often read about but fail to recognize their brilliance and contribution to history, to our present-day, and our future. History is more than just words on a page; it is past lives and experiences recorded for us to learn for the purpose of better living—if we choose.

Many ancient cultures championed curcumin. Ayurvedic medicine is one of the oldest forms of medicine originating from India thousands of years ago. Some estimate 3,000 years ago, others estimate 6,000. The exact age is open for debate. The point is that Ayurvedic medicine has stood the test of time and still stands tall. In actuality, that is the largest, longest observational study in history!

In contrast, conventional medicine has not stood the test of any time at all, starting early in the 20th century. In pure numbers, that is roughly 3,000-6,000 years to 100. Curcumin, via the spice turmeric (curcumin longa), is a mainstay of Ayurvedic medicine [1]. In addition, ancient Asian cultures, including traditional Chinese Medicine (TCM), have used the same curcumin for its medicinal properties. Even the ancient Greek physicians used curcumin. These cultures represent some of the brightest and most intellectually advancing times in the history of the world. Not only did these ancient cultures approve of curcumin, but they also spread it to the world. If curcumin did not stand the test of time, it would have never passed beyond the ancients.

The problem with Curcumin

The problem with curcumin is different than you may think. No therapy, even natural and holistic treatments, is without questions and issues. Science, is in part, the debate of scientific ideas. Without different opinions and scientific discussions, there is no foundation for real science. Any exclusion of debate in science is the de-platform of this foundation for a new type of uniform religion of science where discussion and descent are not allowed under the threat of religious persecution.

There are some problems, more perceived problems, with curcumin. It is essential to be clear that the research, the volume of research, and the mechanism of action of curcumin are not the problems. First, curcumin is not new. What kind of problem is that? Curcumin is not the new shiny pharmaceutical wonder drug that is launched with millions of dollars of marketing. Curcumin doesn’t have a heavily researched and funded avatar running down the beach with butterflies following in its wake. More, it allows it to be overlooked and marginalized by researchers. Second, curcumin is natural. To most of us, that is a good thing and provides instant credibility, but to most in conventional medicine and the government bureaucracy, it discredits and marginalizes it. Third, curcumin has low bioavailability when taken orally. Curcumin is poorly absorbed through the gastrointestinal tract resulting in lower systemic levels. The result is low biological effects. Studies have pointed to the need to take up to 8 grams of oral curcumin to overcome this limited bioavailability. That is a lot of pills and a lot of spice on the stomach and doesn’t go down too well. The low bioavailability of curcumin is not a permanent roadblock but a simple detour overcome through intravenous administration. This low curcumin oral bioavailability is very similar to the shortcomings of vitamin C that are overcome through intravenous administration [2]. Finally, at this point in history, natural products, such as curcumin, are not patentable. From the conventional, bureaucratic mindset, this is grounds for instant marginalization because of the lack of profits.

How does Curcumin work against cancer?

This specific post will not dive into all the details and specifics of the anti-cancer effects of curcumin. I have the receipts, and the mechanisms will come in later posts backed with the large volume of evidence to support it. To set the stage, the broad-based, anti-cancer effects of Curcumin target:

Oh, but there is more. Curcumin helps increase chemotherapy and radiation sensitivity, it helps to overcome treatment resistance, and it is an excellent adjuvant therapy to ANY cancer treatment program. These few points alone provide sufficient evidence to support the general use of curcumin in cancer treatment—the specifics of the mechanisms of the how are just icing on the cake for those who follow the biochemistry.

Without question, the anti-cancer effects of curcumin reach far beyond this preliminary evidence-based list. There is not a more effective anti-cancer therapy available. But of course, curcumin is God-made, not human-made, and that is the problem. Stay tuned!

[1] Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65(11):1631-1652. doi:10.1007/s00018-008-7452-4

[2] Chen Q, Espey MG, Sun AY, et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A. 2007;104(21):8749-8754. doi:10.1073/pnas.0702854104

[3] Xu Y, Zhang J, Han J, et al. Curcumin inhibits tumor proliferation induced by neutrophil elastase through the upregulation of α1-antitrypsin in lung cancer. Mol Oncol. 2012;6(4):405-417. doi:10.1016/j.molonc.2012.03.005

[4] Moghaddam SJ, Barta P, Mirabolfathinejad SG, Ammar-Aouchiche Z, Torres Garza N, Vo TT, Newman RA, Aggarwal BB, Evans CM, Tuvim MJ, Lotan R, Dickey BF. Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. Carcinogenesis. Nov 2009; 30(11):1949–1956.

[5] Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. Oct 2008;269(2):199-225. doi: 10.1016/j.canlet.2008.03.009.

[6] Shakeri A, Ward N, Panahi Y, Sahebkar A. Anti-Angiogenic Activity of Curcumin in Cancer Therapy: A Narrative Review. Curr Vasc Pharmacol. 2019;17(3):262-269. doi: 10.2174/1570161116666180209113014.

[7] Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM, Lutgendorf SK, Aggarwal BB, Sood AK. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res. June 2007;13(11):3423-30. doi: 10.1158/1078-0432.CCR-06-3072.

[8] Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, Patumraj S. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J Gastroenterol. Apr 2008;14(13):2003-9. doi: 10.3748/wjg.14.2003.

[9] Wang N, Feng T, Liu X, Liu Q. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway. Acta Pharm. Sep 2020;70(3):399-409. doi: 10.2478/acph-2020-0029.

[10] Chen QY, Zheng Y, Jiao DM, Chen FY, Hu HZ, Wu YQ, Song J, Yan J, Wu LJ, Lv GY. Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway. J Nutr Biochem. Feb 2014;25(2):177-85. doi: 10.1016/j.jnutbio.2013.10.004.

[11] Tian S, Liao L, Zhou Q, et al. Curcumin inhibits the growth of liver cancer by impairing myeloid-derived suppressor cells in murine tumor tissues. Oncol Lett. 2021;21(4):286. doi:10.3892/ol.2021.12547

[12] Srivastava NS, Srivastava RAJ. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells. Phytomedicine. Jan 2019; 52:117-128.

[13] Woo JH, Kim YH, Choi YJ, Kim DG, Lee KS, Bae JH, Min DS, Chang JS, Jeong YJ, Lee YH, Park JW, Kwon TK. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-X L and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis. Jul 2003;24(7):1199–1208,

[14] Singh, M., Singh, N. Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Mol Cell Biochem. 2009;325:107–119.

[15] Mortezaee K, Salehi E, Mirtavoos-Mahyari H, Motevaseli E, Najafi M, Farhood B, Rosengren RJ, Sahebkar A. Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy. J Cell Physiol. Aug 2019;234(8):12537-12550. doi: 10.1002/jcp.28122.

[16] Amin AR, Haque A, Rahman MA, Chen ZG, Khuri FR, Shin DM. Curcumin induces apoptosis of upper aerodigestive tract cancer cells by targeting multiple pathways. PLoS One. 2015;10(4):e0124218.

[17] Karunagaran D, Rashmi R, Kumar TR. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets. Mar 2005;5(2):117-29. doi: 10.2174/1568009053202081.

[18] Siddiqui FA, Prakasam G, Chattopadhyay S, Rehman AU, Padder RA, Ansari MA, Irshad R, Mangalhara K, Bamezai RNK, Husain M, Ali SM, Iqbal MA. Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition. Sci Rep. May 2018;8(1):8323. doi: 10.1038/s41598-018-25524-3.

[19] Yadav S, Bhagat SD, Gupta A. et al. Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer. BMC Cancer. 2019;19(1031).

[20] Vishvakarma, N.K. Novel antitumor mechanisms of curcumin: implication of altered tumor metabolism, reconstituted tumor microenvironment and augmented myelopoiesis. Phytochem Rev. 2014;13:717–724.

[21] Pani S, Sahoo A, Patra A, Debata PR. Phytocompounds curcumin, quercetin, indole-3-carbinol, and resveratrol modulate lactate-pyruvate level along with cytotoxic activity in HeLa cervical cancer cells. Biotechnol Appl Biochem. Oct 2020. doi: 10.1002/bab.2061.

[22] Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem. Pharmacol. 2008;76:1340-1351.

[23] Kötting C, Hofmann L, Lotfi R, Engelhardt D, Laban S, Schuler PJ, Hoffmann TK, Brunner C, Theodoraki M-N. Immune-Stimulatory Effects of Curcumin on the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma. Cancers. 2021;13(6):1335.

[24] Mukherjee S, Baidoo JNE, Fried A, Banerjee P. Using curcumin to turn the innate immune system against cancer. Biochem Pharmacol. 2020 Jun;176:113824. doi: 10.1016/j.bcp.2020.113824.

[25] Vishvakarma, N.K. Novel antitumor mechanisms of curcumin: implication of altered tumor metabolism, reconstituted tumor microenvironment and augmented myelopoiesis. Phytochem Rev. 2014;13:717–724.

[26] Zhang Y, Xue Y-b, Li H, Qiu D, Wang Z-w, Tan S-s. Inhibition of Cell Survival by Curcumin Is Associated with Downregulation of Cell Division Cycle 20 (Cdc20) in Pancreatic Cancer Cells. Nutrients. 2017; 9(2):109.

[27] Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D. et al. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene. 2001;20:7597–7609.

[28] Bose S, Panda AK, Mukherjee S, Sa G. Curcumin and tumor immune-editing: resurrecting the immune system. Cell Div. Oct 2015;10:6. doi: 10.1186/s13008-015-0012-z.

[29] Zhang CY, Zhang L, Yu HX, Bao JD, Lu RR. Curcumin inhibits the metastasis of K1 papillary thyroid cancer cells via modulating E-cadherin and matrix metalloproteinase-9 expression. Biotechnol Lett. Jul 2013;35(7):995-1000. doi: 10.1007/s10529-013-1173-y.

[30] Zong H, Wang F, Fan Qx et al. Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways. Mol Biol Rep. 2012; 39:4803–4808.

[31] Zhang Z, Chen H, Xu C, Song L, Huang L, Lai Y, Wang Y, Chen H, Gu D, Ren L, Ren L, et al. Curcumin inhibits tumor epithelial‑mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells. Oncol Rep. 2016; 35: 2615-2623.

[32] Maheshwari RK, Singh AK, Gaddipati J and Srimal RC: Multiple biological activities of curcumin: A short review. Life Sci. 2006; 78:2081–2087.

[33] Marzbani E, Inatsuka C, Lu H, Disis ML. The Invisible Arm of Immunity in Common Cancer Chemoprevention Agents. Cancer Prev Res. Aug 2013;6(8):764-773; DOI: 10.1158/1940-6207.CAPR-13-0036

[34] Ashrafizadeh M, Zarrabi A, Hushmandi K, Zarrin V, Moghadam ER, Hashemi F, Makvandi P, Samarghandian S, Khan H, Hashemi F, Najafi M, Mirzaei H. Toward Regulatory Effects of Curcumin on Transforming Growth Factor-Beta Across Different Diseases: A Review. Front Pharmacol. Dec 2020;11:585413. doi: 10.3389/fphar.2020.585413

[35] Tian S, Liao L, Zhou Q, et al. Curcumin inhibits the growth of liver cancer by impairing myeloid-derived suppressor cells in murine tumor tissues. Oncol Lett. 2021;21(4):286. doi:10.3892/ol.2021.12547

[36] Wang Y, Lu J, Jiang B, Guo J. The roles of curcumin in regulating the tumor immunosuppressive microenvironment. Oncol Lett. Apr 2020;19(4):3059-3070. doi: 10.3892/ol.2020.11437.

[37] Piccolella M, Crippa V, Messi E, Tetel MJ, Poletti A. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells. Pharmacological research. Jan 2014;79:13-20.

[38] Schaaf C, Shan B, Buchfelder M, Losa M, Kreutzer J, Rachinger W, Stalla GK, Schilling T, Arzt E, Perone MJ, Renner U. Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo. Endocr Relat Cancer. Dec 2009;16(4):1339-50. doi: 10.1677/ERC-09-0129.

[39] Coker-Gurkan A, Celik M, Ugur M, Arisan ED, Obakan-Yerlikaya P, Durdu ZB, Palavan-Unsal N. Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells. Amino Acids. Aug 2018;50(8):1045-1069. doi: 10.1007/s00726-018-2581-z.

[40] Abd Wahab NA, Lajis NH, Abas F, Othman I, Naidu R. Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer. Nutrients. 2020;12(3):679. doi:10.3390/nu12030679

[41] Hassan F, Rehman MS, Khan MS, Ali MA, Javed A, Nawaz A, Yang C. Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects. Front Genet. Jun 2019.

[42] Yadav S, Bhagat SD, Gupta A. et al. Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer. BMC Cancer. 2019;19,1031.

[43] Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr. 2011;6(2):93-108. doi:10.1007/s12263-011-0222-1

[44] Muppala S, Konduru SKP. (2020) Crucial Role of Curcumin in Gut Microbiota Associated with GI Cancers. In: Nagaraju G.P. (eds) Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers. Springer, Cham.

[45] Weng W, Goel A. Curcumin and colorectal cancer: An update and current perspective on this natural medicine. Seminars in Cancer Biology. Feb 2020.

[46] Huang F, Yao Y, Wu J, Liu Q, Zhang J, Pu X, et al. Curcumin Inhibits Gastric Cancer-Derived Mesenchymal Stem Cells Mediated Angiogenesis by Regulating NF-κb/VEGF Signaling. Am J Trans Res. 2017; 9(12):5538-47.

[47] Buhrmann C, Kraehe P, Lueders C, Shayan P, Goel A, Shakibaei M. Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT. PLoS One. Sep 2014;9(9):e107514. doi: 10.1371/journal.pone.0107514.

[48] James MI, Iwuji C, Irving G, Karmokar A, Higgins JA, Griffin-Teal N, Thomas A, Greaves P, Cai H, Patel SR, Morgan B, Dennison A, Metcalfe M, Garcea G, Lloyd DM, Berry DP, Steward WP, Howells LM, Brown K. Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy. Cancer Lett. Aug 2015; 10;364(2):135-41. doi: 10.1016/j.canlet.2015.05.005.

[49] Ramasamy TS, Ayob AZ, Myint HH, Thiagarajah S, Amini F. Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy. Cancer Cell International. 2015;15:96. DOI: 10.1186/s12935-015-0241-x.

[50] Zang S, Liu T, Shi J, Qiao L. Curcumin: a promising agent targeting cancer stem cells. Anticancer Agents Med Chem. 2014;14(6):787-92. doi: 10.2174/1871520614666140521114735. PMID: 24851881.

[51] Zendehdel E, Abdollahi E, Momtazi-Borojeni AA, Korani M, Alavizadeh SH, Sahebkar A. The molecular mechanisms of curcumin’s inhibitory effects on cancer stem cells. J Cell Biochem. Apr 2019;120(4):4739-4747. doi: 10.1002/jcb.27757.

Would you like to speak with a caring member of our team to answer your specific questions? Call (480) 834-5414